Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Bristol-Myers Squibb Co. for $17.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Bristol-Myers Squibb Co. (BMY)


Adjustments to Financial Statements

High level of difficulty


Adjustments to Current Assets

Bristol-Myers Squibb Co., adjusted current assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Current assets hidden hidden hidden hidden hidden
Adjustments
Add: Bad debt allowances hidden hidden hidden hidden hidden
Less: Deferred income tax assets, current1 hidden hidden hidden hidden hidden
After Adjustment
Adjusted current assets hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

1 Deferred income tax assets, current. See Details »


Adjustments to Total Assets

Bristol-Myers Squibb Co., adjusted total assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Total assets hidden hidden hidden hidden hidden
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1 hidden hidden hidden hidden hidden
Add: Bad debt allowances hidden hidden hidden hidden hidden
Less: Deferred income tax assets, current2 hidden hidden hidden hidden hidden
Less: Deferred income tax assets, non-current3 hidden hidden hidden hidden hidden
After Adjustment
Adjusted total assets hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See Details »

2 Deferred income tax assets, current. See Details »

3 Deferred income tax assets, non-current. See Details »


Adjustments to Current Liabilities

Bristol-Myers Squibb Co., adjusted current liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Current liabilities hidden hidden hidden hidden hidden
Adjustments
Less: Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale or Income taxes payable)1 hidden hidden hidden hidden hidden
Less: Deferred income, current portion hidden hidden hidden hidden hidden
Less: Restructuring liability, current hidden hidden hidden hidden hidden
After Adjustment
Adjusted current liabilities hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

1 Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale or Income taxes payable). See Details »


Adjustments to Total Liabilities

Bristol-Myers Squibb Co., adjusted total liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Total liabilities hidden hidden hidden hidden hidden
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1 hidden hidden hidden hidden hidden
Less: Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale or Income taxes payable)2 hidden hidden hidden hidden hidden
Less: Deferred income tax liabilities, non-current (included in Income taxes payable)3 hidden hidden hidden hidden hidden
Less: Deferred income hidden hidden hidden hidden hidden
Less: Restructuring liability hidden hidden hidden hidden hidden
After Adjustment
Adjusted total liabilities hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

1 Operating lease liability (before adoption of FASB Topic 842). See Details »

2 Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale or Income taxes payable). See Details »

3 Deferred income tax liabilities, non-current (included in Income taxes payable). See Details »


Adjustments to Stockholders’ Equity

Bristol-Myers Squibb Co., adjusted total Bristol-Myers Squibb Company shareholders’ equity

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Total Bristol-Myers Squibb Company shareholders’ equity hidden hidden hidden hidden hidden
Adjustments
Less: Deferred tax assets (liabilities), net1 hidden hidden hidden hidden hidden
Add: Bad debt allowances hidden hidden hidden hidden hidden
Add: Deferred income hidden hidden hidden hidden hidden
Add: Restructuring liability hidden hidden hidden hidden hidden
Add: Noncontrolling interest hidden hidden hidden hidden hidden
After Adjustment
Adjusted total Bristol-Myers Squibb Company shareholders’ equity hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

1 Deferred tax assets (liabilities), net. See Details »


Adjustments to Capitalization Table

Bristol-Myers Squibb Co., adjusted capitalization table

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Short-term debt obligations hidden hidden hidden hidden hidden
Long-term debt, excluding current portion hidden hidden hidden hidden hidden
Total reported debt hidden hidden hidden hidden hidden
Total Bristol-Myers Squibb Company shareholders’ equity hidden hidden hidden hidden hidden
Total reported capital hidden hidden hidden hidden hidden
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1 hidden hidden hidden hidden hidden
Adjusted total debt hidden hidden hidden hidden hidden
Adjustments to Equity
Less: Deferred tax assets (liabilities), net2 hidden hidden hidden hidden hidden
Add: Bad debt allowances hidden hidden hidden hidden hidden
Add: Deferred income hidden hidden hidden hidden hidden
Add: Restructuring liability hidden hidden hidden hidden hidden
Add: Noncontrolling interest hidden hidden hidden hidden hidden
Adjusted total Bristol-Myers Squibb Company shareholders’ equity hidden hidden hidden hidden hidden
After Adjustment
Adjusted total capital hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

1 Operating lease liability (before adoption of FASB Topic 842). See Details »

2 Deferred tax assets (liabilities), net. See Details »


Adjustments to Revenues

Bristol-Myers Squibb Co., adjusted revenues

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Revenues hidden hidden hidden hidden hidden
Adjustments
Add: Increase (decrease) in deferred income hidden hidden hidden hidden hidden
After Adjustment
Adjusted revenues hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).


Adjustments to Reported Income

Bristol-Myers Squibb Co., adjusted net earnings attributable to BMS

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Net earnings attributable to BMS hidden hidden hidden hidden hidden
Adjustments
Add: Deferred income tax expense (benefit)1 hidden hidden hidden hidden hidden
Add: Increase (decrease) in bad debt allowances hidden hidden hidden hidden hidden
Add: Increase (decrease) in deferred income hidden hidden hidden hidden hidden
Add: Increase (decrease) in restructuring liability hidden hidden hidden hidden hidden
Add: Other comprehensive income (loss) hidden hidden hidden hidden hidden
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest hidden hidden hidden hidden hidden
After Adjustment
Adjusted net earnings attributable to BMS hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

1 Deferred income tax expense (benefit). See Details »